Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C A, Svenson M, Nielsen J H
Diabetologia. 1986 Jan;29(1):63-7. doi: 10.1007/BF02427283.
Addition of highly purified human Interleukin-1 to the culture medium of isolated rat islets of Langerhans for 6 days led to 88% inhibition of glucose-induced insulin-release, reduction of islet contents of insulin and glucagon to 31% and 8% respectively, and disintegration of the islets. These effects were dose-dependent and reproducible when using three different Interleukin-1 preparations. Highly purified human Interleukin-2, Lymphotoxin, Leucocyte Migration Inhibitory Factor and Macrophage Migration Inhibitory Factor were ineffective. These findings suggest that Interleukin-1 may play an important role in the molecular mechanisms underlying autoimmune B-cell destruction leading to Type 1 (insulin-dependent) diabetes mellitus.
向分离出的大鼠胰岛朗格汉斯细胞的培养基中添加高纯度人白细胞介素-1,持续6天,导致葡萄糖诱导的胰岛素释放受到88%的抑制,胰岛中胰岛素和胰高血糖素的含量分别降至31%和8%,胰岛解体。当使用三种不同的白细胞介素-1制剂时,这些效应具有剂量依赖性且可重复。高纯度人白细胞介素-2、淋巴毒素、白细胞迁移抑制因子和巨噬细胞迁移抑制因子均无效。这些发现表明,白细胞介素-1可能在导致1型(胰岛素依赖型)糖尿病的自身免疫性B细胞破坏的分子机制中起重要作用。